United States, 5 and a half year

Ryleas was diagnosed with Optic Nerve Hypoplasia, an abnormal deficiency of cells: in her case ONH was extremely severe, resulting in her complete loss of vision. Such a condition is normally linked with hormonal imbalances in the brain which can affect a child's growth, although in Rylea’s case Optic Nerve Hypoplasia does not seem to have affected her in being a very lively and happy child. Sight apart, in all other respects Rylea is healthy and energetic.

Through stem cell treatment her family hoped to restore the cell count in the nerves and to see some response to visual stimulus, specifically pupil dilation or retraction. Rylea’s treatment (umbilical cord stem cell injections with visual rehabilitation therapy) began on July 3rd, 2007.

Reportage By DAN J. BEILSTEIN - The Observer, 14 May 2008
Diese E-Mail-Adresse ist gegen Spambots geschützt! JavaScript muss aktiviert werden, damit sie angezeigt werden kann.

SOUTH DAYTONA — Six months ago, former Port Orange resident Abby Wolfe said she would do anything for her 18-month-old son, Elioe “Tre” Burgos III. Elioe’s vision was thought to be no better than 20/1200. He was blind, and diagnosed with Optic Nerve Hypoplasia (ONH). Doctors informed Ms. Wolfe and Elioe Burgos Sr. that young Elioe suffered from an underdevelopment of his optic nerve. According to doctors, ONH is not progressive or inherited. Ms. Wolfe’s decision to embark on a medical journey involved researching umbilical cord stem cell treatments to grow cells needed to help improve Elioe’s sight. But, that meant raising money to pay for the operations and travel to China — where stem cell research is legal. The frustrated parents soon learned there were no medical facilities in the United States that offered the treatment Elioe needed. Next stop, China.